Menopause and CHD risk: New perspectives

Research output: Contribution to journalReview articlepeer-review


Estrogen treatment is being increasingly recommended for treatment of hypercholesterolemia in postmenopausal women and for those with evidence of coronary disease. A number of studies have shown significant lipid benefits with this treatment, and an association with marked falls in cardiovascular disease mortality. At a Fournier symposium presentation, R. Knopp suggested that, in accordance with current approaches to treatment of hyperlipidemia that focus on those individuals at highest risk, it may be particularly appropriate to recommend estrogen therapy for postmenopausal women at high risk for coronary heart disease, including those with diabetes, dyslipidemia, hypertension, those who smoke cigarettes, and particularly, those with existing coronary disease.

Original languageEnglish
Pages (from-to)10-11+54
JournalCardiovascular Reviews and Reports
Issue number9
StatePublished - 1995


Dive into the research topics of 'Menopause and CHD risk: New perspectives'. Together they form a unique fingerprint.

Cite this